|
Metformin vs. Metformin plus second generation Sulfonylureas |
|||
| Missing |
P |
Int |
Inc |
| (XP) |
(XI) |
(XInc) |
|
|
|
|||
| XGa |
-3.82 ± 1.43 |
[-6.11, -2.88] ± [1.15, 1.53] |
-0.73 ± 1.74 |
Ma et al. BMC Medical Research Methodology 2008 8:56 doi:10.1186/1471-2288-8-56 |
|||